Score Overview
Explore the 2021 public Archive ranking →
Where Apyx Medical Inc has ranked, year by year
Showing 1 year ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- APYX
1997: 12.3% · 2021: 38.7% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-30 | $ 2.45 | — |
1 Year2025-09-30 | $ 2.14 | 14.49% |
5 Years2021-09-30 | $ 13.85 | -82.31% |
10 Years2016-09-30 | $ 5.21 | -52.98% |
20 Years2006-09-29 | $ 7.04 | -65.20% |
30 Years1996-09-30 | $ 1.13 | 117.78% |
| Period | Last Price2026-09-30 | 1 Year2025-09-30 | 5 Years2021-09-30 | 10 Years2016-09-30 | 20 Years2006-09-29 | 30 Years1996-09-30 |
|---|---|---|---|---|---|---|
| Price | $ 2.45 | $ 2.14 | $ 13.85 | $ 5.21 | $ 7.04 | $ 1.13 |
| Return | — | 14.49% | -82.31% | -52.98% | -65.20% | 117.78% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 58M | -$ 8M | $ 27M |
| 2025 | $ 52M | -$ 11M | $ 31M |
| 2024 | $ 48M | -$ 23M | $ 31M |
| 2023 | $ 52M | -$ 18M | $ 43M |
| 2022 | $ 44M | -$ 23M | $ 10M |
| 2021 | $ 48M | -$ 15M | $ 30M |
| 2020 | $ 27M | -$ 11M | $ 41M |
| 2019 | $ 28M | -$ 19M | $ 58M |
| 2018 | $ 16M | $ 64M | $ 78M |
| 2017 | $ 38M | -$ 5M | $ 9M |
| 2016 | $ 36M | -$ 3M | $ 14M |
| 2015 | $ 29M | -$ 5M | $ 11M |
| 2014 | $ 27M | -$ 17M | $ 5M |
| 2013 | $ 23M | -$ 4M | $ 7M |
| 2012 | $ 27M | $ 617K | $ 4M |
| 2011 | $ 25M | $ 109K | $ 4M |
| 2010 | $ 24M | -$ 1M | $ 3M |
| 2009 | $ 26M | $ 595.52K | $ 2M |
| 2008 | $ 28M | $ 1M | $ 2M |
| 2007 | $ 28M | $ 2M | $ 3M |
| 2006 | $ 26M | $ 2M | $ 2M |
| 2005 | $ 20M | $ 406.21K | $ 1M |
| 2004 | $ 20M | $ 1M | $ 2M |
| 2003 | $ 16M | $ 681.32K | $ 306.14K |
| 2002 | $ 12M | -$ 514.76K | $ 379.21K |
| 2001 | $ 11M | $ 784.29K | $ 578.35K |
| 2000 | $ 9M | $ 500.63K | $ 278.66K |
| 1999 | $ 9M | -$ 2M | $ 415.07K |
| 1998 | $ 8M | -$ 998.05K | $ 278.67K |
| 1997 | $ 7M | $ 99.19K | $ 48.25K |
| 1996 | $ 7M | $ 407.3K | $ 120.9K |
| 1995 | $ 5M | -$ 154.1K | $ 165.8K |
Apyx Medical Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 27M to $ 52M and net income went from -$ 11M to -$ 11M. Revenue increased in 3 of those 5 years; net income in 3.
Across Apyx Medical Inc's full reported history, from 1995 to 2025, revenue grew from $ 5M to $ 52M and net income went from -$ 154.1K to -$ 11M. Revenue increased in 68% of the years measured; net income in 48%.
Apyx Medical Inc currently holds a 20-year HDB Score of 2.9 out of 10. How the HDB Score is calculated.
Membership
Continue APYX’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
